These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 18164509)

  • 1. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
    Rudholm N
    Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independently owned pharmacy closures in rural America.
    Boyle K; Ullrich F; Mueller K
    Rural Policy Brief; 2012 Jul; (2012 4):1-4. PubMed ID: 22830100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A question of emphasis: efficiency or equality in the provision of pharmaceuticals.
    Almarsdóttir AB; Morgall JM; Björnsdóttir I
    Int J Health Plann Manage; 2000; 15(2):149-61. PubMed ID: 11009948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries.
    Vogler S; Habimana K; Arts D
    Health Policy; 2014 Sep; 117(3):311-27. PubMed ID: 24962537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing competition in the pharmacy sector: lessons from Iceland and Norway.
    Anell A; Hjelmgren J
    Appl Health Econ Health Policy; 2002; 1(3):149-56. PubMed ID: 14619266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liberalization and integration of drug distribution in the EU 28 and Norway.
    Písek J; Pícha K
    Ceska Slov Farm; 2018; 67(1):14-24. PubMed ID: 30157663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of prescription medications and ancillary pharmacy services among rural elders in west Texas: distance barriers and implications for telepharmacy.
    Collins B; Borders TF; Tebrink K; Xu KT
    J Health Hum Serv Adm; 2007; 30(1):75-97. PubMed ID: 17557697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs: just a click away. Online pharmacies can make dangerous drugs easy to get, but also can promote better health care. Should we regulate them?
    Brand R
    State Legis; 2007 Jun; 33(6):45, 47, 49. PubMed ID: 17546803
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of the additional costs of dispensing workers' compensation prescriptions.
    Schafermeyer KW
    Res Social Adm Pharm; 2007 Mar; 3(1):123-36. PubMed ID: 17350561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulating the pharmacy market: the case of Iceland and Norway.
    Anell A
    Health Policy; 2005 Dec; 75(1):9-17. PubMed ID: 16298225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of the compliance with good pharmacy practice in an urban and rural district in Sri Lanka.
    Wijesinghe PR; Jayakody RL; De A Seneviratne R
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):197-206. PubMed ID: 17152112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany.
    Stargardt T; Schreyögg J; Busse R
    Health Policy; 2007 Nov; 84(1):30-8. PubMed ID: 17553587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independently owned pharmacy closures in rural America, 2003-2010.
    Boyle K; Ullrich F; Mueller K
    Rural Policy Brief; 2011 Jun; (2011 5):1-4. PubMed ID: 21736184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future economic outlook of Nebraska rural community pharmacies based on break-even analysis of community operational costs and county population.
    Keast SL; Jacobs E; Harrison D; Farmer K; Thompson D
    Res Social Adm Pharm; 2010 Sep; 6(3):209-20. PubMed ID: 20813334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical care in community pharmacies: practice and research in Estonia.
    Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
    Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability of essential medicines in Ethiopia: an efficiency-equity trade-off?
    Carasso BS; Lagarde M; Tesfaye A; Palmer N
    Trop Med Int Health; 2009 Nov; 14(11):1394-400. PubMed ID: 19754520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.
    Lee YC; Huang KH; Huang YT
    Health Policy Plan; 2007 Nov; 22(6):427-35. PubMed ID: 17901065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The financial impact of OBRA-90 on community pharmacies: an overview.
    Nightengale B; Reeder CE
    Clin Ther; 1993; 15(3):581-92. PubMed ID: 8364950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of managed care on the retail distribution of pharmaceuticals.
    Carroll NV
    Manag Care Interface; 1998 Nov; 11(11):105-8, 111-3. PubMed ID: 10187415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.